1 / 23

Chapter 5 Diffuse Interstitial Pulmonary Fibrosis

Chapter 5 Diffuse Interstitial Pulmonary Fibrosis. Topics. Pathology of diffuse interstitial pulmonary fibrosis Normal alveolar wall structure Reduced lung volumes and compliance Pressure-volume curves Diffusion across the blood-gas barrier Diffusing capacity. Case Study #5: Elena.

Download Presentation

Chapter 5 Diffuse Interstitial Pulmonary Fibrosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 5Diffuse Interstitial Pulmonary Fibrosis

  2. Topics • Pathology of diffuse interstitial pulmonary fibrosis • Normal alveolar wall structure • Reduced lung volumes and compliance • Pressure-volume curves • Diffusion across the blood-gas barrier • Diffusing capacity

  3. Case Study #5: Elena • 40 yr old Blues singer • Dyspnea and fatigue • 5 years ago symptoms worsened • Weight loss and unusual fatigue • Irritating, unproductive cough • No family history of pulm disease • No apparent toxic exposure

  4. Physical exam #5: Elena • Drawn • Rapid, shallow breathing • Poor inspiratory movement • Crackles on inspiration • Clubbed fingers • Loud pulmonary second sound (indicative of R side HF)

  5. Investigations • Normal hemoglobin and cell counts • Small contracted lung and rib cage • Raised diaphragm

  6. Exercise and pulm function tests • Vo2 max: 2.2 L/min • Stopped because of SOB • Look at very low Po2 values • Why? • DLCO

  7. Lung Biopsy • Definitive diagnosis • Marked thickening of alveolar walls • Extensive collagen deposition • Capillary obliteration • Cause: unknown

  8. Normal histology and Pathology • Restrictive lung disease • No obstruction • Small volumes • Interstitial disease affects the parenchyma (tissue) • Normal vs. restrictive alveolar wall

  9. Alveolar anatomy • Normally • Blood-gas barrier: ~ 0.3 um • Alveolar epithelium, interstitium, capillary endothelium • Type I cell • Chief structural cell of alveoli • Structural • Collagen • Type II cell • Epithelial • Globular • Little structural support • Metabolically active • Forms surfactant • In injury, transformed into type I cells

  10. Alveolar anatomy II • Other cells • Macrophages • Scavenge foreign particles and bacteria • Fibroblasts • Synthesize collagen and elastin • In fibrosis; large amts of collagen are laid down in interstitium of alveolar wall

  11. Alveolar anatomy III • Interstitium • Space between alveolar epithelium and capillary endothelium • Usu. Thin • Provides integrity and strength to BG barrier • Vulnerable to stress

  12. Pathology of Diffuse Interstitial Pulmonary Fibrosis • Many synonyms • Idiopathic pulmonary fibrosis • Interstitial pneumonia (inflammation and flooding) • Cryptogenic fibrosing alveolitis • Principal features • Thickening of the interstitium • Collagen deposition • Infiltration with lymphocytes • Fibroblasts lay down collagen • Desquamation: cellular exudate (containing macrophages) in alveoli • Destruction of alveolar architecture • “Honeycomb” lung; scarring of lung (resists stretching)

  13. Physiology and pathophysiology • Clinical findings • Chief complaint: dyspnea • Caused by stiff lung • Reduced compliance • Shallow, rapid breathing • Physical exam • Crepitations on inspiration caused by fibrotic lesions • Loud 2cd pulmonary sound: hypertension • Caused by wholesale destruction of pulm caps • Chest radiograph • Small lung

  14. Pulmonary function tests • Right shifted compliance curve (low) • Very low lung volumes

  15. Pulmonary function in fibrosis • Relaxation pressure-volume curve • Fig 5-6 • FRC: lung and chest wall forces are equal • Above FRC: • Lung+chest wall forces are positive • Greater tendency for recoil • Below FRC: • They are negative • Greater tendency for expansion • Obstructive disease: FRC increases; why? • Restrictive disease: FRC decreases; why?

  16. Forced expiration • FVC decreased • FEV1.0/FVC: normal • Elevated FEF25-75% • Rapid exhalation; why? • Little dynamic compression • Scarring supports the airways and holds them open

  17. Arterial blood gases • Hypoxemia; why? • VA/Q mismatch • Destruction of capillaries • Derangement of alveolar architecture • Diffusion limitation • Thickened BG barrier

  18. Diffusion across Blood-gas barrier • Diffusion limitation vs perfusion limitation • CO: diffusion limited • Binds very strongly to Hb • Thus, partial pressure changes very little; why? • No back-pressure • Transfer limited by properties of blood-gas barrier • N2O: perfusion limited • NO combination with Hb • Dissolves in plasma • Partial pressure rises rapidly • Transfer limited by blood flow • O2? • Can be both

  19. Diffusion across Blood-gas barrier • So, O2 is perfusion limited in health, where the rise in partial pressure is rapid due to the lower affinity of Hb for O2 and the very high diffusing capacity • In disease, when the diffusion capacity is reduced, then O2 becomes diffusion limited • Also, diffusion of a gas depends upon it’s solubility in both the BG barrier AND the blood • If the same, no diffusion limitation • If different, diffusion limited • Thus, BG barrier thickness increase can limit diffusion

  20. Measurement of diffusing capacity • Carbon monoxide: • Diffusion limited gas • V gas = A/T x (P1-P2) x D • V gas = DL (P1-P2) • DL = diffusing capacity of the lung • Includes area, thickness and diffusive properties of membrane and gas • DL = Vco/(P1-P2) • DL = Vco/PAco • Vol of CO transferred per unit pressure CO

  21. Measurement of diffusing capacity • Usu. Subject takes a breath of dilute CO mixture (0.3%) and exhales • Conc difference between inspired and exhaled measured; rate of disappearance measured • Rx rate with Hb • Not all resistance to transfer lies in membrane • Some lies in the Rx rate with Hb • Two stages • Diffusion through BG barrier (includes plasma and RBC membrane) • Rx rate with Hb

  22. Measurement of diffusing capacity • These two “resistances” produce the overall “resistance to diffusion” • Overall “conductance” is the inverse of these resistances (see Fig. 5-9) • DL = diffusing capacity of the lung • DM = diffusing capacity of the “membrane” • Θ = rx rate with Hb • Vc = capillary blood vol

  23. Why is Elena’s diffusing capacity reduced? • Reduced membrane conductance • Reduced Vc • Perhaps also due to unequal VA/Q

More Related